Listed

Strata Critical Medical, Inc.

SRTANasdaqCIK 1779128HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$72.5m, Q2 FY2026
Operating income−$5.4m, Q2 FY2026
Net income−$10.5m, Q2 FY2026
Strata Critical Medical, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m71.4Revenue, Q3 FY2023, three months to 2023-09-30$71.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure47.5Revenue, Q4 FY2023, three months to 2023-12-31$47.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0001779128-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure51.5Revenue, Q1 FY2024, three months to 2024-03-31$51.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure67.9Revenue, Q2 FY2024, three months to 2024-06-30$67.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure36.1Revenue, Q3 FY2024, three months to 2024-09-30$36.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure36.4Revenue, Q4 FY2024, three months to 2024-12-31$36.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure35.9Revenue, Q1 FY2025, three months to 2025-03-31$35.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure45.1Revenue, Q2 FY2025, three months to 2025-06-30$45.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure49.3Revenue, Q3 FY2025, three months to 2025-09-30$49.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure66.8Revenue, Q4 FY2025, three months to 2025-12-31$66.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure67.4Revenue, Q1 FY2026, three months to 2026-03-31$67.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure72.5Revenue, Q2 FY2026, three months to 2026-06-30$72.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Cost of revenue$m55.9Cost of revenue, Q3 FY2023, three months to 2023-09-30$55.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure38.5Cost of revenue, Q4 FY2023, three months to 2023-12-31$38.5m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-13, accession 0001779128-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure41.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$41.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure51.6Cost of revenue, Q2 FY2024, three months to 2024-06-30$51.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure28.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$28.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure31.4Cost of revenue, Q4 FY2024, three months to 2024-12-31$31.4m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure28.9Cost of revenue, Q1 FY2025, three months to 2025-03-31$28.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure36.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$36.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure37.7Cost of revenue, Q3 FY2025, three months to 2025-09-30$37.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure55.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$55.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure53.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$53.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure57.3Cost of revenue, Q2 FY2026, three months to 2026-06-30$57.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Gross profit$m15.6Gross profit, Q3 FY2023, three months to 2023-09-30$15.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2023-11-08, accession 0001779128-23-000121.Report this figurenot reportednot reportednot reportednot reportednot reported7.1Gross profit, Q1 FY2025, three months to 2025-03-31$7.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure9.0Gross profit, Q2 FY2025, three months to 2025-06-30$9.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figurenot reportednot reported14.1Gross profit, Q1 FY2026, three months to 2026-03-31$14.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure15.2Gross profit, Q2 FY2026, three months to 2026-06-30$15.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reported12.3Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$12.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure13.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$13.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figurenot reportednot reported15.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$15.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure14.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$14.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Operating income$m(7.4)Operating income, Q3 FY2023, three months to 2023-09-30−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure(35.6)Operating income, Q4 FY2023, three months to 2023-12-31−$35.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0001779128-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure(9.9)Operating income, Q1 FY2024, three months to 2024-03-31−$9.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure(12.1)Operating income, Q2 FY2024, three months to 2024-06-30−$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure(7.1)Operating income, Q3 FY2024, three months to 2024-09-30−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure(5.9)Operating income, Q4 FY2024, three months to 2024-12-31−$5.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure(5.7)Operating income, Q1 FY2025, three months to 2025-03-31−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(4.6)Operating income, Q2 FY2025, three months to 2025-06-30−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure(5.6)Operating income, Q3 FY2025, three months to 2025-09-30−$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure(6.4)Operating income, Q4 FY2025, three months to 2025-12-31−$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure(3.0)Operating income, Q1 FY2026, three months to 2026-03-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(5.4)Operating income, Q2 FY2026, three months to 2026-06-30−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Income tax$m0.1Income tax, Q3 FY2023, three months to 2023-09-30$129.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure(1.0)Income tax, Q4 FY2023, three months to 2023-12-31−$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-13, accession 0001779128-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure(0.1)Income tax, Q1 FY2024, three months to 2024-03-31−$84.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$52.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Net income$m0.3Net income, Q3 FY2023, three months to 2023-09-30$289.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure(33.9)Net income, Q4 FY2023, three months to 2023-12-31−$33.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0001779128-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure(4.2)Net income, Q1 FY2024, three months to 2024-03-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure(11.3)Net income, Q2 FY2024, three months to 2024-06-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure(2.0)Net income, Q3 FY2024, three months to 2024-09-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure(9.8)Net income, Q4 FY2024, three months to 2024-12-31−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure(3.5)Net income, Q1 FY2025, three months to 2025-03-31−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(3.7)Net income, Q2 FY2025, three months to 2025-06-30−$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure57.4Net income, Q3 FY2025, three months to 2025-09-30$57.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure(8.8)Net income, Q4 FY2025, three months to 2025-12-31−$8.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure2.2Net income, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(10.5)Net income, Q2 FY2026, three months to 2026-06-30−$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Diluted EPS$ per share0.00Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure(0.15)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure(0.03)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(0.05)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure0.70Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figurenot reported0.03Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(0.12)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Basic EPS$ per share0.00Basic EPS, Q3 FY2023, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figurenot reported(0.06)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure(0.15)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure(0.03)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figurenot reported(0.04)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(0.05)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure0.70Basic EPS, Q3 FY2025, three months to 2025-09-30$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figurenot reported0.03Basic EPS, Q1 FY2026, three months to 2026-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(0.12)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure

Balance sheet

Cash and equivalents$16.3m, Q2 FY2026
Shareholders' equity$279.3m, Q2 FY2026
Strata Critical Medical, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m36.8Cash and equivalents, Q3 FY2023, at 2023-09-30$36.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure27.9Cash and equivalents, FY2023, at 2023-12-31$27.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0001779128-25-000010.Report this figure36.8Cash and equivalents, Q1 FY2024, at 2024-03-31$36.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure26.3Cash and equivalents, Q2 FY2024, at 2024-06-30$26.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure20.0Cash and equivalents, Q3 FY2024, at 2024-09-30$20.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure18.4Cash and equivalents, FY2024, at 2024-12-31$18.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-03, accession 0001628280-26-013628.Report this figure34.8Cash and equivalents, Q1 FY2025, at 2025-03-31$34.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure58.8Cash and equivalents, Q2 FY2025, at 2025-06-30$58.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure22.8Cash and equivalents, Q3 FY2025, at 2025-09-30$22.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure31.0Cash and equivalents, FY2025, at 2025-12-31$31.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-03, accession 0001628280-26-013628.Report this figure58.7Cash and equivalents, Q1 FY2026, at 2026-03-31$58.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure16.3Cash and equivalents, Q2 FY2026, at 2026-06-30$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Current assets$m209Current assets, Q3 FY2023, at 2023-09-30$208.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001779128-23-000121.Report this figure206Current assets, FY2023, at 2023-12-31$206.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0001779128-25-000010.Report this figure194Current assets, Q1 FY2024, at 2024-03-31$194.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001779128-24-000068.Report this figure183Current assets, Q2 FY2024, at 2024-06-30$182.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001779128-24-000097.Report this figure172Current assets, Q3 FY2024, at 2024-09-30$171.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure161Current assets, FY2024, at 2024-12-31$160.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-03, accession 0001628280-26-013628.Report this figure152Current assets, Q1 FY2025, at 2025-03-31$152.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure156Current assets, Q2 FY2025, at 2025-06-30$156.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure122Current assets, Q3 FY2025, at 2025-09-30$122.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure126Current assets, FY2025, at 2025-12-31$126.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure124Current assets, Q1 FY2026, at 2026-03-31$124.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure121Current assets, Q2 FY2026, at 2026-06-30$121.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Total assets$m318Total assets, Q3 FY2023, at 2023-09-30$317.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001779128-23-000121.Report this figure295Total assets, FY2023, at 2023-12-31$294.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0001779128-25-000010.Report this figure283Total assets, Q1 FY2024, at 2024-03-31$282.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001779128-24-000068.Report this figure280Total assets, Q2 FY2024, at 2024-06-30$280.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001779128-24-000097.Report this figure283Total assets, Q3 FY2024, at 2024-09-30$282.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure257Total assets, FY2024, at 2024-12-31$256.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-03, accession 0001628280-26-013628.Report this figure251Total assets, Q1 FY2025, at 2025-03-31$250.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure258Total assets, Q2 FY2025, at 2025-06-30$257.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure335Total assets, Q3 FY2025, at 2025-09-30$335.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure325Total assets, FY2025, at 2025-12-31$325.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure328Total assets, Q1 FY2026, at 2026-03-31$327.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure333Total assets, Q2 FY2026, at 2026-06-30$332.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Current liabilities$m30.4Current liabilities, Q3 FY2023, at 2023-09-30$30.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001779128-23-000121.Report this figure35.5Current liabilities, FY2023, at 2023-12-31$35.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0001779128-25-000010.Report this figure23.2Current liabilities, Q1 FY2024, at 2024-03-31$23.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001779128-24-000068.Report this figure30.3Current liabilities, Q2 FY2024, at 2024-06-30$30.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001779128-24-000097.Report this figure27.2Current liabilities, Q3 FY2024, at 2024-09-30$27.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure22.7Current liabilities, FY2024, at 2024-12-31$22.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-03, accession 0001628280-26-013628.Report this figure21.9Current liabilities, Q1 FY2025, at 2025-03-31$21.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure26.3Current liabilities, Q2 FY2025, at 2025-06-30$26.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure27.9Current liabilities, Q3 FY2025, at 2025-09-30$27.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure19.8Current liabilities, FY2025, at 2025-12-31$19.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure20.9Current liabilities, Q1 FY2026, at 2026-03-31$20.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure45.8Current liabilities, Q2 FY2026, at 2026-06-30$45.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Total liabilities$m54.6Total liabilities, Q3 FY2023, at 2023-09-30$54.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001779128-23-000121.Report this figure60.6Total liabilities, FY2023, at 2023-12-31$60.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0001779128-25-000010.Report this figure46.2Total liabilities, Q1 FY2024, at 2024-03-31$46.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001779128-24-000068.Report this figure50.9Total liabilities, Q2 FY2024, at 2024-06-30$50.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001779128-24-000097.Report this figure49.4Total liabilities, Q3 FY2024, at 2024-09-30$49.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure34.7Total liabilities, FY2024, at 2024-12-31$34.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-03, accession 0001628280-26-013628.Report this figure30.8Total liabilities, Q1 FY2025, at 2025-03-31$30.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure34.8Total liabilities, Q2 FY2025, at 2025-06-30$34.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure52.1Total liabilities, Q3 FY2025, at 2025-09-30$52.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure46.4Total liabilities, FY2025, at 2025-12-31$46.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure41.9Total liabilities, Q1 FY2026, at 2026-03-31$41.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure53.4Total liabilities, Q2 FY2026, at 2026-06-30$53.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m263Shareholders' equity, Q3 FY2023, at 2023-09-30$262.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure234Shareholders' equity, FY2023, at 2023-12-31$234.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-03, accession 0001628280-26-013628.Report this figure237Shareholders' equity, Q1 FY2024, at 2024-03-31$236.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure229Shareholders' equity, Q2 FY2024, at 2024-06-30$229.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure233Shareholders' equity, Q3 FY2024, at 2024-09-30$233.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure222Shareholders' equity, FY2024, at 2024-12-31$221.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure220Shareholders' equity, Q1 FY2025, at 2025-03-31$219.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure223Shareholders' equity, Q2 FY2025, at 2025-06-30$223.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure283Shareholders' equity, Q3 FY2025, at 2025-09-30$283.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure279Shareholders' equity, FY2025, at 2025-12-31$279.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure286Shareholders' equity, Q1 FY2026, at 2026-03-31$285.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure279Shareholders' equity, Q2 FY2026, at 2026-06-30$279.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure

Cash flow

Operating cash flow$5.7m, Q2 FY2026
Capital expenditure$2.5m, Q2 FY2026
Share repurchases$0, Q4 FY2025
Strata Critical Medical, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m2.0Operating cash flow, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001779128-24-000126. Derived: 9-month figure less the 6-month figure.Report this figure(9.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0001779128-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure(15.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure8.4Operating cash flow, Q2 FY2024, three months to 2024-06-30$8.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001779128-25-000060. Derived: 6-month figure less the 3-month figure.Report this figure6.4Operating cash flow, Q3 FY2024, three months to 2024-09-30$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001628280-25-050870. Derived: 9-month figure less the 6-month figure.Report this figure(1.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure(0.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$246.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure(3.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001628280-26-052256. Derived: 6-month figure less the 3-month figure.Report this figure(37.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$37.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001628280-25-050870. Derived: 9-month figure less the 6-month figure.Report this figure(8.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure3.9Operating cash flow, Q1 FY2026, three months to 2026-03-31$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure5.7Operating cash flow, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001628280-26-052256. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$695.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001779128-24-000126. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-13, accession 0001779128-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$816.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure16.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$16.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001779128-25-000060. Derived: 6-month figure less the 3-month figure.Report this figure9.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001628280-25-050870. Derived: 9-month figure less the 6-month figure.Report this figure4.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$4.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure2.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure2.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001628280-26-052256. Derived: 6-month figure less the 3-month figure.Report this figure2.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001628280-25-050870. Derived: 9-month figure less the 6-month figure.Report this figure1.8Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figure5.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure2.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001628280-26-052256. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-12, accession 0001779128-24-000126. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-13, accession 0001779128-25-000010. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-10, accession 0001628280-25-050870. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-10, accession 0001628280-25-050870. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-03, accession 0001628280-26-013628. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)86.21m, Q2 FY2026
Strata Critical Medical, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares71.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3071,466,085 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001779128-23-000121.Report this figure72.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3171,992,771 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001779128-24-000068.Report this figure73.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3073,169,003 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001779128-24-000097.Report this figure81.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3081,006,859 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001779128-24-000126.Report this figure75.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3175,796,411 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001779128-25-000042.Report this figure77.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3077,603,604 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001779128-25-000060.Report this figure78.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3078,044,254 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure79.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3179,891,829 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure81.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3081,297,402 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure82.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3082,454,657 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001628280-25-050870.Report this figure90.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3190,168,853 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-031032.Report this figure86.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3086,213,930 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure

Shares outstanding: 88.47mShares outstanding, period not labelled, at 2026-07-2888,466,806 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001628280-26-052256.Report this figure at Jul 28, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.